idiopathic pulmonary fibrosis

  • 网络特发性肺纤维化;特发性肺间质纤维化;性肺纤维化
idiopathic pulmonary fibrosisidiopathic pulmonary fibrosis
  1. Protein C Anticoagulant System in Patients with Idiopathic Pulmonary Fibrosis

    特发性肺纤维化患者蛋白C系统的研究

  2. Idiopathic Pulmonary Fibrosis : Correlation between Helical CT Features and Clinical Stage

    特发性肺纤维化的螺旋CT表现特征与临床病程的相关性

  3. Review on research and drug therapeutic effect of the Idiopathic Pulmonary Fibrosis

    特发性肺间质纤维化的研究及其药物疗效的回顾

  4. These morphologic changes provide basis for formation of idiopathic pulmonary fibrosis .

    上述形态学改变对特发性肺纤维化的形成提供了一些依据。

  5. Experimental imaging studies of early - stage idiopathic pulmonary fibrosis - animal model and preliminary results

    实验性特发性肺纤维化的早期影像研究&动物模型的建立

  6. High Resolution CT Evaluation of Idiopathic Pulmonary Fibrosis

    特发性肺纤维化的高分辨率CT评价

  7. Clinical Study on Treatment of Idiopathic Pulmonary Fibrosis with the Capsule of Solving Fibrosis

    化纤胶囊治疗特发性肺间质纤维化的临床研究

  8. Objective To observe ultrastructural changes and study the pathogenesis of idiopathic pulmonary fibrosis .

    目的观察特发性肺纤维化的超微结构变化并探讨其发病机理。

  9. Lung function tests and corticosteroid therapy in idiopathic pulmonary fibrosis

    特发性肺纤维化肺功能测定与激素治疗

  10. Experiment in vivo : ① Establishment of the model rats of idiopathic pulmonary fibrosis .

    总体实验:①建立大鼠肺纤维化模型;

  11. Diagnostic Value of Left Ventricular Geometry and Function by Echocardiography in Idiopathic Pulmonary Fibrosis

    特发性肺纤维化左心构型及功能的超声心动图诊断价值初探

  12. Pathogenesis and treatment progress of idiopathic pulmonary fibrosis

    特发性肺间质纤维化发病机制及治疗进展

  13. Effects of BCG-PSN Combined with Glucocorticoid on Patients with Idiopathic Pulmonary Fibrosis

    卡介菌多糖核酸与糖皮质激素联合应用对特发性肺纤维化的抑制作用

  14. Significance of Chemiluminescence of Inflammatory Cells in BAL in Idiopathic Pulmonary Fibrosis

    特发性肺纤维化患者肺灌洗液炎症细胞化学发光检测的意义

  15. Changes on the protein kinase C activity of alveolar macrophages in patients with idiopathic pulmonary fibrosis

    肺间质病患者肺泡巨噬细胞蛋白激酶C活性的变化

  16. The HRCT appearances of idiopathic pulmonary fibrosis and other interstitial lung disease

    特发性肺间质纤维化与其它肺间质性病变的HRCT表现

  17. Treatment of idiopathic pulmonary fibrosis with cytokines

    细胞因子治疗特发性肺纤维化

  18. Idiopathic pulmonary fibrosis ; Tumor biomarkers ; Prognosis ;

    特发性肺纤维化;肿瘤标志物;预后;

  19. The Measurement of Glutathione in Bronchoalveolar Lavage Fluid with Idiopathic Pulmonary Fibrosis

    特发性肺纤维化患者支气管肺泡灌洗液谷胱甘肽的检测

  20. Study on the Treatment of Idiopathic Pulmonary Fibrosis with Prednisone , N-acetylcysteine Combined Captopril

    强的松、N-乙酰半胱氨酸和卡托普利联合治疗特发性肺纤维化

  21. Objective : Acute idiopathic pulmonary fibrosis ( AIPF ) is a rare disease .

    目的:急性特发性肺间质纤维化是少见疾病。

  22. Changes of Cyclic Nucleotides and Nitric Oxide in the Plasma of Patients with Idiopathic Pulmonary Fibrosis

    特发性肺纤维化患者血浆环核苷酸和一氧化氮水平研究

  23. Objective : To Study the effects and feasibility of life quality list for idiopathic pulmonary fibrosis ( IPF ) patients .

    目的:探讨研究特发性肺纤维化患者的生存质量评价体系,评估生存质量测评表对特发性肺纤维化患者评价的可行性。

  24. Conclusions Mutations in the genes encoding telomerase components can appear as familial idiopathic pulmonary fibrosis .

    结论:端粒酶组分的编码基因发生突变时,能以家庭性特发性肺纤维变性的形式出现。

  25. Methods Helical CT scan was performed on 45 patients with clinically or pathologically proved idiopathic pulmonary fibrosis .

    方法收集经临床病理证实的IPF45例,全部行螺旋CT检查,其中25例对兴趣区追加高分辨率CT扫描。

  26. Significance of over expression of DcR_3 gene in peripheral blood mononuclear cells of the patients with idiopathic pulmonary fibrosis

    特发性肺间质纤维化病人外周血单核细胞中DcR3基因表达的意义

  27. Acute Idiopathic Pulmonary Fibrosis

    急性特发性肺间质纤维化

  28. Idiopathic pulmonary fibrosis , which has no known cause , affects 70,000 to 200,000 Americans , according to various estimates .

    特发性肺纤维化的原因尚不明确,各类数据显示,美国的患病人数在7万到20万之间。

  29. Objective To study high-resolution CT ( HRCT ) diagnosis and differential diagnosis of idiopathic pulmonary fibrosis ( IPF ) .

    目的探讨高分辨率CT(HRCT)对特发性肺纤维化(IPF)的诊断及鉴别诊断的价值。

  30. PFD was used as multi-target drug and was approved in Japan for the treatment of idiopathic pulmonary fibrosis .

    该药物于2008年11月在日本上市,用于治疗特发性肺纤维化。